Two biotechnology companies are designing therapies to deliver edited genes to treat Friedreich’s ataxia and amyotrophic lateral sclerosis, or ALS. . . . → Read More: Biotechs Partner on Crispr Therapies for Neuro Disorders
|
|||||
|
       
  |
A synthetic biology company and genetics research service are providing analytics on population genomic variations they say are more racially and ethnically diverse. . . . → Read More: Diverse Genomic Variation Analytics Panel Created 
A bioengineering team created a practical technique for using DNA as a medium to store and retrieve vast and rapidly growing volumes of data. . . . → Read More: DNA Data Search, Retrieval Medium Designed 
A genetic analysis identifies a single genetic variation associated with loss of smell and taste, an early symptom in many people with Covid-19 infections. . . . → Read More: Genetic Link Found for Covid-19 Loss of Smell 
A company combining computational genetic analysis and precision medicine discovery for cancer therapies is raising $43 million in its first venture round. . . . → Read More: Precision Cancer Meds Company Raises $43M in Early Funds  Comments are closed  Finance, New products  Asia, biomedical, biotechnology, cancer, chemistry, engineering, entrepreneurs, equity, genomics, investment, life sciences, mathematics, physical sciences, university 
Moderna Inc. and South Korea signed agreements Saturday on joint research and manufacturing opportunities for vaccines against viruses in Korea. . . . → Read More: Moderna Expands Vaccine Research, Mfring in Asia 2 comments - (Comments are closed) Joint ventures/collaborations Asia, biomedical, biotechnology, Covid-19, genomics, Japan, Korea, life sciences, manufacturing, pharmaceuticals 
A developer of gene editing for inherited heart disease reports lab monkeys given its therapy experience lower cholesterol levels for at least eight months. . . . → Read More: Crispr Treatment Leads to Durable Cholesterol Reduction Comments are closed New products biomedical, biotechnology, entrepreneurs, genomics, heart disease, life sciences, pharmaceuticals, preclinical, university 
A new company is underway commercializing research on gene therapies for inherited diseases, staked to an initial investment of $200 million. . . . → Read More: Gene Therapy Company Starts-Up, Gains $200M Comments are closed Intellectual property, New products Asia, biomedical, biotechnology, entrepreneurs, equity, genomics, investment, licensing, life sciences, pharmaceuticals, university, venture capital 
A biotechnology company began work in public to develop new treatments that target proteins responsible for gene expression, beginning with cancer. . . . → Read More: New Biotech Creating Precision Cancer Therapies One comment - (Comments are closed) Finance, New products biomedical, biotechnology, chemistry, entrepreneurs, equity, genomics, investment, life sciences, pharmaceuticals, physical sciences, U.K., university, venture capital 
A company developing synthetic biology and engineering tools for biotechnology is becoming a public company through a special-purpose acquisition. . . . → Read More: Synthetic Bio Company Goes Public in $2.5B Merger Comments are closed Finance biotechnology, economics, engineering, entrepreneurs, equity, genomics, investment, IPO, life sciences, merger, pharmaceuticals |
||||
|
Copyright © 2021 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||